Novel amodiaquine derivatives potently inhibit Ebola virus infection

Ebola virus disease is a severe disease caused by highly pathogenic Ebolaviruses. Although it shows a high mortality rate in humans, currently there is no licensed therapeutic. During the recent epidemic in West Africa, it was demonstrated that administration of antimalarial medication containing am...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Yasuteru, Sakakibara, Norikazu, Toyama, Masaaki, Baba, Masanori, Davey, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374029/
https://www.ncbi.nlm.nih.gov/pubmed/30395872
http://dx.doi.org/10.1016/j.antiviral.2018.10.025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374029/
https://www.ncbi.nlm.nih.gov/pubmed/30395872
http://dx.doi.org/10.1016/j.antiviral.2018.10.025

Ejemplares similares